|
|||||
|
|
Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase |
|
| Authors: | Katerina Machova Polakova Vojtech Kulvait Adela Benesova Jana Linhartova Hana Klamova Monika Jaruskova Caterina de Benedittis Torsten Haferlach Michele Baccarani Giovanni Martinelli Tomas Stopka Thomas Ernst Andreas Hochhaus Alexander Kohlmann Simona Soverini |
| Affiliation: | 1. Institute of Hematology and Blood Transfusion, Prague, Czech Republic 2. First Faculty of Medicine, Institute of Clinical and Experimental Hematology, Charles University, Prague, Czech Republic 3. PersMed, Dolni Brezany, Czech Republic 4. First Faculty of Medicine, Institute of Pathologic Physiology, Charles University, Prague, Czech Republic 5. Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology “L. e A. Seràgnoli”, University of Bologna, Bologna, Italy 6. MLL Munich Leukemia Laboratory, Munich, Germany 7. Abteilung für H?matologie/Onkologie, Klinik für Innere Medizin II, Universit?tsklinikum Jena, Jena, Germany 8. AstraZeneca, Personalized Healthcare and Biomarkers, Innovative Medicines, Cambridge, UK |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |